Scientists at Johns Hopkins University have overturned a three-decade-old scientific assumption about how the human eye develops its center of sharpest focus, finding that the process depends on a precisely timed interaction between a Vitamin A derivative and thyroid hormones inside the developing fetal retina.
The study, published in the Proceedings of the National Academy of Sciences and highlighted by ScienceDaily on July 9, 2026, discovered that blue cone cells in the foveola — the eye's tiny center responsible for the sharpest, highest-resolution vision — do not simply migrate away from the center during fetal development as scientists had long believed. Instead, those blue cones transform into red and green cones through an active cellular conversion process driven by molecular signals.
